sodium thiosulfate has been researched along with Metabolic Skin Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MDP; Ernste, FC; Ma, JE; Wetter, DA | 1 |
| Wollina, U | 1 |
1 review(s) available for sodium thiosulfate and Metabolic Skin Diseases
| Article | Year |
|---|---|
[Cutaneous calciphylaxis].
Topics: Biopsy; Bone Density Conservation Agents; Calciphylaxis; Chelating Agents; Combined Modality Therapy; Debridement; Diagnosis, Differential; Diphosphonates; Ergocalciferols; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Necrosis; Negative-Pressure Wound Therapy; Prognosis; Risk Factors; Skin; Skin Diseases, Metabolic; Thiosulfates | 2010 |
1 other study(ies) available for sodium thiosulfate and Metabolic Skin Diseases
| Article | Year |
|---|---|
Topical sodium thiosulfate for calcinosis cutis associated with autoimmune connective tissue diseases: the Mayo Clinic experience, 2012-2017.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Juvenile; Arthritis, Rheumatoid; Autoimmune Diseases; Calcinosis; Chelating Agents; Connective Tissue Diseases; Dermatomyositis; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Retrospective Studies; Scleroderma, Systemic; Skin Diseases, Metabolic; Thiosulfates; Undifferentiated Connective Tissue Diseases; Young Adult | 2019 |